The OP of this thread asked about official guidelines for stopping the Mounjaro prescriptions. The following article has some info on page 15.
“Patient monitoring, reviewing and stopping”.
Apparently, according to the article, there are no official guidelines for stopping. To quote from info in the link
“
Mounjaro does not have a set stopping rule, or maximum treatment period, allowing for indefinite prescribing.”
This suggests that it is up to individual patients and their prescribing clinician to consider all circumstances when deciding on whether or not to continue.
I have only scan read the article, but there are many interesting points. A Few I picked out of personal interest include:-
The phased implementation to those patients with highest clinical need.
The need for ‘wraparound care, including advice on nutrition, diet, behavioural change being mandatory.
The medication being a ‘Black Triangle Drug’.
The fact that it is a ‘Black Triangle Drug’ could be another reason for the phased introduction, aside from the cost implications to NHS. I.e. it is a new treatment which has not had longitudinal study to assess any long term ill effects. As someone who has previously been prescribed ‘cures’ for my obesity, including Tenuate Dospan, (amphetamine) and Orlistat (prevents absorption of dietary fats) which caused me adverse effects, I would be very wary about starting any weight loss drugs. Particularly any ‘Black Triangle’ meds. Of course we each have to do our own, personal evaluations and risk assessments in making our choices, and some will still be restricted by Integrated Care Boards, and individual clinicians in how they interpret the criteria set out.
*Edited to remove reference to previously edited post and to provide clarity . Pipp.